🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Florid › Miami

Etid klinik pou Dyabèt Tip 2 nan Miami, FL

19 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Finlay Medical Research Corp, Miami
  • Optimus U Corporation-Miami-69452, Miami
  • Oceane7 Clinical Research, Miami
  • ak 3 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • New Horizon Research Center-Miami-69732, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07223333

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Ap rekriteVolontè an sante akeyi
  • Fiel Wellness Clinical Research LLC, Miami
  • BioPhase Research, Miami
  • United Clinical Research, Miami
  • ak 4 plis
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
  • New Horizon Research Center, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Ap rekriteFaz 2
  • Bioclinical Research Alliance, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • LCC Medical Research Institute, Miami
  • D&H National Research Centers, Inc, Miami
  • Regenerate Primary Medical Research, LLC, Miami
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Admed Research LLC, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Optimus U Corporation, Miami
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Ap rekriteFaz 3
  • Life Spring Research Foundation LLC, Miami
  • Optimus U, Corp, Miami
  • Flourish Research - North Miami, Miami
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Ap rekriteFaz 3
  • D&H National Research Centers, Inc, Miami
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes

Ap rekriteFaz 1
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 65 · Tout sèks · Mizajou May 6, 2026 · NCT07568678

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • Avantis Clinical Research, Miami
  • IMIC Research, Miami
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Ap rekriteFaz 2
  • GTL Medical & Research Group, Miami
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT07282743

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

Ap rekriteFaz 1Volontè an sante akeyi
  • Syneos Miami, Miami
Laj 18 a 80 · Tout sèks · Mizajou Mar 13, 2026 · NCT07385547

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

Ap rekriteFaz 1/2
  • Bascom Palmer Eye Institute, Miami
  • Diabetes Research Institute, University of Miami Miller School of Medicine, Miami
Laj 18 a 75 · Tout sèks · Mizajou Mar 12, 2026 · NCT02846571

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Ap rekrite
  • Clever Medical Research, Miami
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT06681428

RESET System Pivotal Trial (Rev F)

Ap rekrite
  • University of Miami Hospital, Miami
Laj 22 a 65 · Tout sèks · Mizajou Jul 18, 2024 · NCT04101669

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.